Abstract Paneth cells at the base of small intestinal crypts of Lieberkühn secrete high levels of a-defensins in response to cholinergic and microbial stimuli. Paneth cell a-defensins are broad spectrum microbicides that function in the extracellular environment of the intestinal lumen, and they are responsible for the majority of secreted bactericidal peptide activity. Paneth cell a-defensins confer immunity to oral infection by Salmonella enterica serovar Typhimurium, and they are major determinants of the composition of the small intestinal microbiome. In addition to host defense molecules such as a-defensins, lysozyme, and Pla2g2a, Paneth cells also produce and release proinflammatory mediators as components of secretory granules. Disruption of Paneth cell homeostasis, with subsequent induction of endoplasmic reticulum stress, autophagy, or apoptosis, contributes to inflammation in diverse genetic and experimental mouse models.
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Paneth cells and the enteric epithelial barrier
A resident microflora and ingested microorganisms represent a continuing infectious challenge to intestinal epithelium. Factors that contribute to mucosal health include transcytosis of secretory IgA, secreted mucus, gastric and pancreatic secretions, bile salts, peristalsis, the resident commensal microflora, exfoliation of enterocytes during epithelial renewal, and CD8? intraepithelial T lymphocytes. In addition, innate host defense mechanisms have evolved to confer immediate biochemical protection against infection and colonization by pathogenic or opportunistic microorganisms. The secretion of geneencoded antimicrobial peptides (AMPs) and host defense proteins by Paneth cells plays a major role in mediating this activity [1] .
Mechanisms that regulate Paneth cell maturation provide insights into their role in innate immunity and in intestinal homeostasis. Four major epithelial cell lineages populate the adult small intestine. Absorptive enterocytes, goblet cells, enteroendocrine cells, and Paneth cells are renewed continually from mitotically-active, transitamplifying cell progenitors that reside in crypts of Lieberkühn [2] [3] [4] [5] [6] [7] . Villus enterocytes, goblet cells and enteroendocrine cells differentiate as they ascend from crypts onto villi [3, 8, 9] . After emergence from the cryptvillus boundary, absorptive enterocytes live 3-5 days, undergo apoptosis near the tips of the villi, and are exfoliated into the lumen. In contrast, Paneth cell progenitors descend to the crypt base as they accumulate lineage-specific products and adopt their remarkable morphology, and label retention experiments estimate Paneth cell lifetimes at approximately 70 days [10, 11] . Paneth cell differentiation requires continuous Wnt signaling via the Frizzled-5 receptor, inducing specific Paneth cell genes, including a-defensins, which are targets of b-catenin-and TCF-4-mediated transcription [10, 12] . Wnts, the Frizzled-5 receptor, and the Math1, Gfi1, and Sox9 transcription factors are required for Paneth cell differentiation [12] , with Sox9 being essential for the appearance of the lineage [13, 14] .
Paneth cells populate the base of the crypts of Lieberkühn in the small intestine of most mammals [1, 15] . These unique cells have an extensively developed endoplasmic reticulum (ER) and Golgi apparatus that direct large dense core granules to the apical membrane for secretion ( Fig. 1) . Paneth cell dense core granules are rich in antibiotic proteins and peptides as well as potent proinflammatory mediators [1, 16, 17] . Diverse Paneth cell gene products include a-defensins, sPLA 2 , lysozyme, lipopolysaccharide-binding protein, matrix metalloproteinase-7 (MMP7), interleukin-17 (IL-17), tumor necrosis factor-alpha (TNF-a), pancreatitis-associated protein 3 or regenerating islet-derived protein III-gamma (RegIII-c), CD95 ligand, IgA, cysteine-rich intestinal polypeptide (CRIP), CD15, and metallothionine, which are found at their highest concentrations in fully differentiated Paneth cells that occupy the crypt base [1] (Fig. 2) . Described as early as 1867, Paneth cells and their diverse, secreted effectors have become increasingly implicated in mucosal health and disease. For example, reports associate disrupted Paneth cell homeostasis with ileitis [18] [19] [20] [21] , their release of proinflammatory mediators in TNF-a-induced shock [16] , and Paneth cells provide key signaling molecules to maintain adult crypt small intestinal stem cell niche [22] .
Paneth cell a-defensins
There are two major AMP families in mammals, the cathelicidins and defensins. Cathelicidins have a phylogenetically conserved precursor structure from which remarkably varied AMPs are derived [23] [24] [25] . Cathelicidin peptides are highly diverse and occur widely, being found in primates, cattle, swine, and rodents, and also in non-mammalian species, including chicken, trout, and the primitive protovertebrate, the Atlantic hagfish, [23] . Defensins were among the first AMPs to be described [26, 27] , and have broad-spectrum antimicrobial activities [28] . The a-defensins are granule constituents of mammalian phagocytes, particularly neutrophils, and of small intestinal Paneth cells [29] . In neutrophil phagolysosomes, the concentration of a-defensins has been estimated at *10 mg/ ml [30] , and mouse Paneth cells secrete a-defensins into the lumen of small intestinal crypts at local concentrations of 25-100 mg/ml at the point of release [31, 32] . The b-defensins are expressed by a great variety of epithelial cell types and at many more sites than the a-defensins, including human kidney, skin, pancreas, gingiva, tongue, esophagus, salivary gland, cornea, and airway epithelium and in epithelial cells of several species [33] . The h-defensins are *2 kDa, tridisulfide bonded, macrocyclic peptides found only in neutrophils and monocytes of Old World monkeys [34] [35] [36] [37] . The biology of defensins as immunomodulatory molecules in the innate and adaptive immune responses have been widely reported and reviewed [38] [39] [40] [41] [42] [43] [44] [45] and will not be considered here.
Human Paneth cells produce two a-defensin peptides, HD-5 and HD-6, which are stored in dense core secretory granules as unprocessed a-defensin precursors. Human pro-HD5 is converted to the major HD5 processed product by anionic and meso isoforms of trypsin after release into the crypt lumen [32] , although alternative proHD5 processing variants have been identified in secretions elicited from human small intestinal crypts in vitro by carbamyl choline [46] . HD5 peptide levels in ileum range from 90 to 450 lg/ cm 2 of mucosal surface area [47] , suggesting that HD5 may attain concentrations of *250 lg/ml in the lumen of adult ileum. HD5 has potent microbicidal activity in in vitro assays, but HD6 lacks such activity in comparable assays [48] . Perhaps HD6 has antifungal or antiviral effects or unanticipated immunomodulatory roles following release into the lumen.
a-Defensin structures
The 3D structures of several a-defensins have been determined by both NMR and X-ray crystallographic techniques [28, 49] , and the 3D structures contain a canonical triplestranded antiparallel b-sheet motif (Fig. 3) . The 3-to 4-kDa a-defensins contain six cysteine residues in canonical disulfide bond pairings that distinguish the individual defensin subfamilies [50, 51] . Although the spacing of cysteine residues and Cys-Cys pairings of disulfide bonds in a-and b-defensins differ, the peptides have remarkably similar folded conformations [52] [53] [54] . The crystal structure of the human neutrophil a-defensin HNP-3 is a non-covalent, amphipathic dimer [55] as are the crystal structures of all human a-defensin peptides [48, 56, 57] . On the other hand, a-defensins from rabbit neutrophils, mouse Paneth cells, and rabbit kidney are monomeric in solution [53, 54, [58] [59] [60] [61] ; see Fig. 5 .
The a-defensins share four canonical structural features (Fig. 4) . Numbering residue positions from the N-termini of the mouse Crp4 and rhesus RMAD-4 mature peptides (Fig. 4) , the conserved features are: (1) the disulfide array, (2) a salt bridge formed by Arg 7 -Glu 15 hydrogen bonds, (3) a conserved Gly at residue position 19, and (4) a high Arg:Lys molar ratio. Most efforts to identify the function(s) of these canonical a-defensin features have focused Arrows denote electron dense secretory granules (G) near the apical surface of a mouse Paneth cell. The dense core granules, surrounded by an electron lucent matrix, are released apically into the lumen, labeled as such, of the crypt by uncharacterized vesicular fusion events. In contrast to the highly fucosylated N-and O-linked glycoprotein components of the electron dense cores, the electron lucent peripheral halo contains GalNAc residues in O-linked oligosaccharides and terminal GlcNAc residues in N-and O-linked glycoconjugates [178] . Box at right contains a partial listing of biologically active proteins confirmed to be constituents of Paneth cell granules Paneth cell a-defensins 2217 on their roles as potential determinants of bactericidal activity. In most instances, mutagenesis at these conserved positions did not alter in vitro bactericidal activity [60, [62] [63] [64] . For example, in the case of the disulfide array, the disulfide bonds confer protection against proteolysis by the activating convertases [62, 63, [65] [66] [67] . Also, mutagenesis of the Arg 7 -Glu 15 salt bridge did not modify bactericidal peptide activity, although salt-bridge variants do not refold as efficiently as native peptides and are more sensitive to proteolysis [60] . These collective findings suggest that the salt bridge and the Gly 19 position may have evolved to provide conserved function(s) in the peptide family that are independent of bactericidal activity, possibly to enable or facilitate efficient chaperone interactions, peptide folding, trafficking in the ER, protection against proteolysis, or receptor-mediated events.
In contrast to comparisons of HNP-1 and Lys-substituted HNP-1 [65] , in vitro bactericidal peptide assays of (R/K)-Crp4 and (R/K)-RMAD-4 in the presence of NaCl showed that both substituted peptides were more sensitive to salt inhibition than the native molecules [68] . Complete Lys for Arg replacements in RMAD-4 did not diminish bactericidal peptide activity or reduce the kinetics of E. coli cell permeabilization, resulting instead in equal or better activities against most bacterial cell targets. Perhaps Arg abundance contributes to optimization of microbicidal activities under higher NaCl concentrations, as a function of the bidentate Arg guanidinium group [69] . The increased sensitivity of Lys substituted Crp4 and RMAD-4 peptides to inhibition by NaCl suggests that the prevalence of Arg as the basic amino acid in a-defensins confers improved bactericidal activity at higher ionic strength. However, in comparisons of native human HNP-1 with a variant containing three Lys for Arg substitutions, HNP-1 was more sensitive to salt inhibition against E. coli than the variant peptide. Although this finding may be due to the low cationicity of HNP-1 relative to Crp4 and RMAD-4, it may be further evidence that effects of a-defensin mutagenesis must be interpreted in the context of individual peptide primary structures.
Mechanisms of a-defensin bactericidal action
The a-defensins are microbicidal against Gram-positive and Gram-negative bacteria, certain fungi, spirochetes, protozoa, and enveloped viruses [28, 70] , and many peptides kill bacteria by distinctive membrane disruptive mechanisms [49] . For example, certain defensins kill bacteria by sequestering lipid II and inhibiting bacterial cell wall biosynthesis [71] [72] [73] , whereas human neutrophil a-defensins mediate non-oxidative microbial cell killing by sequential permeabilization of the outer and inner membranes following phagolysosomal fusion [74] . a-Defensins , a monomeric rabbit a-defensin, HNP-3 (upper right), a dimeric human a-defensin, hBD-1 (lower left), a monomeric human b-defensin, and RTD-1 (lower right), a h-defensin from rhesus macaque [179] . Reprinted from [180] , with permission induce the formation of ion channels in lipid bilayers [74] , and peptide-elicited effects are influenced by cell and membrane energetics [30] . Peptide-induced efflux of potassium ions from bacterial cells is a sensitive indicator of membrane disruption and cell death [75] [76] [77] , and extracellular K ? levels increase markedly and almost immediately when bacteria are exposed to varied Paneth cell a-defensins [64, 78] .
Even though the overall tertiary structure and topology of a-defensins is highly conserved (Fig. 5) , a-defensins with differing primary structures may vary markedly in their membrane disruptive mechanisms. As noted previously, human HNP-3 is a noncovalent dimer, but rabbit neutrophil (NPs), rabbit kidney, and mouse Paneth cell a-defensins are monomers in solution [54, 55, 58, 59] , and the mechanisms by which these distinct molecular forms induce leakage from model membranes in vitro differ. For example, dimeric HNP-2 forms stable, 20-Å multimeric pores after insertion in model phospholipid bilayers [79] , in contrast to rabbit NP-1 monomers which create short-lived defects [80] . The mouse Paneth cell a-defensin Crp4 exhibits strong interfacial binding to model phospholipid membranes [81] , and its induction of graded fluorophore leakage from model membranes, like NPs, depends on peptide concentration and vesicular phospholipid composition [64, 81, 82] .
The canonical a-defensin disulfide arrangement provides critical peptide protection during precursor activation, but it is not a determinant of a-defensin bactericidal activity. Disulfide bond disruption does not induce loss-of-function per se, although native Crp4 is completely resistant to proteolysis by matrix metalloproteinase-7, the mouse pro-a-defensin convertase (see below), all disulfide variants of Crp4 and rhesus neutrophil RMAD-4, even those with just one disulfide mutation, were degraded extensively with loss of all bactericidal activity. The in vitro bactericidal activities of certain a-defensin disulfide variants with disordered structures equal or exceed those of the native Crp4 peptide [62] [63] [64] 66] .
The mechanism of action of the disulfide-null mouse a-defensin cryptdin-4 (Crp4) variant, termed (6C/A)-Crp4, was compared with the native peptide to assess how the two peptides interact with and disrupt phospholipid vesicles of defined composition. Disordered (6C/A)-Crp4 and Crp4 induced similar leakage in live bacteria and model membranes, but the mutant peptide had less overall membranepermeabilizing activity [83] . Crp4 translocates across highly charged or cardiolipin-containing membranes, in a process coupled with membrane permeabilization, but (6C/A)-Crp4 did not translocate lipid bilayers and consistently displayed membrane surface association. Thus, despite the greater in vitro bactericidal activity of (6C/A)-Crp4, native, b-sheet containing Crp4 induces membrane permeabilization more effectively than disulfide-null Crp4 by translocating and forming transient membrane defects.
a-Defensin distribution and gene expression a-Defensins were identified initially as antimicrobial activities in cytoplasmic granules of neutrophils [84] [85] [86] , and subsequent biochemical analyses showed that the molecules were cationic peptides with a tridisulfide array [30] . a-Defensins have been isolated from primate leukocytes and neutrophils of several rodents including rats, rabbits, guinea pigs, and hamsters [28] . Myeloid a-defensin mRNAs are expressed almost exclusively in the bone marrow, where they occur at highest levels in promyelocytes and at lower levels in myeloblasts and myelocytes [87] . Species may differ regarding the leukocyte lineages that express a-defensins as exemplified by the appreciable levels of a-defensins in rabbit alveolar macrophages [26, 27, 88] . Mice are unusual among a-defensin-expressing species in that they lack neutrophil a-defensins [89, 90] . Human monocytes [91] and natural killer (NK) cells [92] express myeloid a-defensins HNP 1-3 constitutively, and microarray experiments have also provided evidence of HNP expression in NK cells [93] . Human CD56? lymphocytes, accumulate HNPs and the human cathelicidin LL-37 [94] , and CD56? NK cell exposure to Klebsiella spp. outer membrane protein A and to E. coli flagellin induces IFN-c production and NK cell release of a-defensins [92] .
Enteric a-defensins are components of Paneth cell secretory granules [46, [95] [96] [97] [98] , and other AMPs, e.g., b-defensins or cathelicidins, have not been detected in the small bowel to my knowledge [99] . In human, rat, mouse, and monkey small intestine, a-defensin transcripts and peptides occur only in Paneth cells, with peptides localizing to dense core secretory granules [78, [96] [97] [98] [100] [101] [102] . In contrast to the numerous and diverse a-defensin genes expressed by mouse and macaque Paneth cells, humans make only two Paneth cell a-defensins, HD5 and HD6 (Fig. 3 ) [102] [103] [104] [105] [106] . Paneth cell a-defensins have also been recovered from luminal rinses of human ileum [32] , from washings of mouse jejunum and ileum [95, 97] , and from the distal colonic lumen [107] .
a-Defensin mRNAs accumulate in small bowel during intestinal development, coinciding with differentiation of the Paneth cell lineage during intestinal crypt ontogeny [108] [109] [110] . Paneth cells differentiate as they descend to the base of the crypt from the proliferative compartment [4, 11] , and Paneth cells populate the base of small intestinal crypts in most mammals [1] . The HD5 and HD6 genes are expressed in the developing human fetus as early as 13.5 weeks of gestation, as detected by RT-PCR, and their appearance coincides with Paneth cell ontogeny during gestation [110, 111] . The expression of HD5 and HD6 genes in utero shows that human Paneth cell a-defensin gene activation is independent of infectious stimuli, as was found in mice [109, 112] .
In mice, certain Crp genes are expressed at a low level in the maturing epithelial cell monolayer of fetal and newborn small intestine in goblet-like cells that are scattered throughout the epithelial sheet [108] .
In humans and mice, Paneth cell a-defensin genes may be expressed in reproductive epithelium as shown by the presence of HD5 in female genital tract epithelia [113, 114] , and HD5 mRNA in normal vagina, ectocervix, endocervix, endometrium, and fallopian tube specimens. The highest endometrial HD5 levels occurred during the early secretory phase of the menstrual cycle, localized to the upper half of the stratified squamous epithelium of the vagina and ectocervix [113] . In endocervix, endometrium, and fallopian tube, HD5 was found in apically-oriented granules and on the apical surface of some columnar epithelial cells. In addition, Paneth cell a-defensins have been detected in human oropharyngeal mucosa [115] . In the mouse, immunoreactive Crp1 has been localized to Sertoli cells and Leydig cells of the testis [116, 117] , and rabbit kidney expresses an a-defensin subset that is distinct from a-defensin peptides isolated from rabbit neutrophils [118, 119] . Despite their expression at these sites, a-defensins occur only in Paneth cells in the small intestine and throughout the gastrointestinal tract [97, 98, 112] .
Although expressed only in small intestinal Paneth cells, enteric a-defensins are abundant in the lumen of mouse colon. Paneth cells are absent or very rare in colon, and colonic epithelium does not express a-defensins [97, 106, [120] [121] [122] [123] , but full-length, intact Paneth cell a-defensins can be recovered in abundance from the colonic lumen, owing to their inherent resistance to proteolysis. Colonic a-defensins have the same overall bactericidal peptide activity as a-defensins from ileal tissue [107] , raising the possibility of their influence on colonic mucosal innate immunity. For example, they may influence the composition of the colonic microflora [124] , although the microbial burden of the colon is several logs greater than distal small intestine. However, because some defensins also inhibit bacterial peptidoglycan biosynthesis by binding to lipid II, it is possible [71] [72] [73] 125] , though highly speculative, that even low colonic a-defensin levels could influence the microbiome population by such a mechanism. Achieving an understanding of the interactions between a-defensins and this microbial ecosystem is complicated, because most commensal microbes are unculturable obligate anaerobes and the effects of a-defensins on these species are largely unexplored.
Regulation of a-defensin biosynthesis
The genetic, epigenetic, translational or posttranslational determinants that regulate a-defensin gene activity and peptide abundance remain unknown. In macaques, mice, and the horse, 20 or more diverse enteric a-defensins are predicted based on cDNA cloning studies [103, 126] . In contrast, dogs and cattle lack a-defensin genes altogether, human Paneth cells have a limited a-defensin repertoire consisting only of HD5 and HD6, and rats express only 5 Paneth cell a-defensin genes. Despite the 20 or more a-defensin genes found in the mouse genome(s), though, only 6 or 7 peptides occur at measureable levels [97] , and similar findings have been made in rhesus macaque (R.A. Llenado et al., unpublished) and horses [126] .
a-Defensin genes map to 8p21-8pter through 8p23 in human, are syntenic in mice [120, 127, 128] , and are expressed predominantly in myeloid cells or in Paneth cells [129] . Myeloid and Paneth cell a-defensin genes differ in that genes expressed in cells of myeloid origin consist of three exons, but those expressed in Paneth cells have two [102, 105, [130] [131] [132] [133] . In Paneth cell a-defensin genes, the 5 0 -untranslated region and the preprosegment are coded by exon 1, but an additional intron interrupts the 5 0 -untranslated region of myeloid a-defensin gene transcripts [134] . Regardless of the site of expression, the 5 0 -distal exon codes for the a-defensin peptide moiety [70, 102, 130, 132, 133, 135] . Studies of cis-acting DNA elements involved in myeloid a-defensin gene regulation identified a short region containing a CAAT box and a putative polyoma enhancer-binding protein 2/core-binding factor (PEBP2/ CBF) site *90 bp upstream of the transcription start site as important for defensin core promoter activity [136] . Despite these advances, the mechanisms that specify myeloid a-defensin gene expression remain obscure.
Events associated with posttranslational pro-a-defensin activation involve proregion cleavage by lineage-specific proteinases, which may occur during granulogenesis in the regulated pathway or after secretion in primate species [137] . Both myeloid and Paneth cell a-defensins derive from *10-kDa prepropeptides consisting of canonical signal sequences, usually acidic proregions, and a *3.5-kDa mature a-defensin peptide in the C-terminal portion of the precursor.
In human and rabbit neutrophils, a-defensins are almost fully processed by primary cleavage steps that leave major intermediates of 75 and 56 amino acids and the mature HNP-1 peptide [137] [138] [139] [140] . In vitro studies implicate the granule serine proteinases elastase, cathepsin G, and proteinase-3 as the activating convertases [62, 141] .
The details of human and mouse Paneth cell a-defensin processing differ. For example, human Paneth cells store unprocessed a-defensin precursors, e.g., proHD5, which is cleaved after secretion by anionic and meso isoforms of trypsin at R62;A63 to produce the predominant form of HD5 [32] . Additional, perhaps alternative, proHD5 processing sites exist as evident from an HD5 variant isolated from human small intestinal crypt secretions elicited with carbamyl choline [46] . Macaque Paneth cell pro-a-defensins may also be processed after secretion by trypsin [103] , because macaque Paneth cell a-defensin precursors have canonical trypsin cleavage sites at residue position 62, the junction of the proregion and the a-defensin N-terminus [103] .
In contrast, in vivo pro-a-defensin activation in mice takes place intracellularly and prior to secretion [112] , and MMP7 gene disruption ablates proCrp processing and impairs innate immunity to oral bacterial infection [142] . Mouse pro-a-defensin processing is mediated by MMP7, the sole pro-a-defensin activating convertase in mouse Paneth cells [112, 142] , which co-localizes with a-defensins and pro-a-defensins in dense core secretory granules [143] . MMP7 produces active 3.5-kDa a-defensins by cleaving precursors in vitro at conserved sites in the proregion and at the junction of the propeptide and the a-defensin [144] , which relieves the inhibitory effects of the covalently linked proregion [144, 145] . In nearly all pro-a-defensins, the electropositive charge of the a-defensin component, essential for bactericidal peptide activity [68, 146] , is balanced or neutralized by anionic amino acid residues in the prosegment. In mouse proCrp4, acidic amino acids clustered near the N terminus of the proregion maintain the precursor in an inhibited state [147] . In the Crp4 precursor, cleavage at Ser 43 ;Ile 44 catalyzed by MMP7 removes 24 amino acid residues from prosegment N-terminus, including 9 acidic amino acids [145] , and is sufficient to activate and enable the full bactericidal and membrane disruptive behavior of Crp4 [145, 147] .
Mouse a-defensin genomics
In mice, and only in mice, a-defensin-related genes code for two subfamilies of cysteine-rich sequence (CRS) peptides, CRS1C and CRS4C [78, [148] [149] [150] [151] [152] . Also expressed specifically by Paneth cells, CRS and Crp mRNA levels in Paneth cells are approximately the same, and the concentrations of both mRNA subfamilies increase coordinately during postnatal crypt ontogeny [148] . Like the a-defensins [151] , CRS peptides are coded by linked genes with conserved two-exon structures [91, 153] . The first exons of CRS genes and Crp genes are highly conserved in that their nucleotide sequences and deduced prepro regions are almost identical (Fig. 6) . However, the peptide-coding second exons of CRS genes diverge markedly from the a-defensin-coding Crp genes [148, 149, 151] . CRS1C and CRS4C peptides contain 11 or 9 Cys residues, respectively, in a series of 9 [148, 151] . The mouse CRS1C and CRS4C genes are more closely related to rat enteric adefensin genes than to any a-defensin gene known in mouse (Fig. 7) , which is unexpected but consistent with mouse a-defensin and CRS1C/4C-coding genes being evolutionarily distinct [120] .
[C]-[X]-[Y] (CRS1C) or 7 [C]-[P]-[Y] (CRS4C) triplet repeats
Homodimeric and heterodimeric forms of CRS4C isoforms were detected in protein extracts, and both CRS4C forms behaved similarly in in vitro bactericidal peptide assays [152] . CRS4C-coding genes exhibit a regional expression pattern, with highest CRS4C mRNA levels in ileum with nearly undetectable levels in proximal small intestine [78] . CRS4C-1 peptides also occur in Paneth cell dense core granules, and thus are secreted to function in the intestinal lumen.
CRS4C bactericidal peptide activity is membranedisruptive in that it permeabilizes E. coli and induces rapid microbial cell K ? efflux, but in a manner different from mouse a-defensin cryptdin-4 [78] . In vitro, inactive pro-CRS4C-1 is converted to bactericidal CRS4C-1 peptide by MMP7 proteolysis of the precursor proregion at the same residue positions that MMP7 activates mouse pro-adefensins. The absence of processed CRS4C in protein extracts of MMP7-null mouse ileum demonstrates the in vivo requirement for intracellular MMP7 in pro-CRS4C processing [78] .
Mice of the SAMP1/YitFc strain, derived from the SAMP1/Yit strain [154] , develop chronic ileitis that resembles human Crohn's disease as early as 10 weeks of age, with perianal disease with ulceration and fistulae in *5% of mice. Prior to histologic evidence of ileitis, SAMP1/YitFc mouse Paneth cell levels of CRS4C mRNAs and peptides increase more than 1,000-fold relative to nonprone strains as early as 4 weeks of age. Possibly, unusually high levels of CRS4C peptide secretion into the SAMP1/YitFc mouse ileum could influence the composition of the microbiome, leading to ileitis in these mice. However, because CRS4C-coding genes are unique to the mouse genome [90, 120, 153] , CRS4C overproduction cannot be directly relevant to human disease. Plausibly, CRS4C overexpression could induce inflammation by disrupting Paneth cell homeostasis leading to increased sensitivity to proinflammatory stimuli with resultant ileitis [15, [19] [20] [21] 155] . Because (1) CRS4C peptide accumulation is high before histologically detectable ileitis in SAMP1/YitFc mice, (2) SAMP1/YitFc mice still develop attenuated ileitis in the absence of intestinal microflora [156] , and (3) membrane-active CRS4C peptides are highly unstable and fold inefficiently in vitro, we speculate that high CRS4C protein expression in SAMP1/YitFc mice may induce Paneth cell ER stress, perhaps increasing sensitivity to additional proinflammatory stimuli and initiating the ileitis.
The primary structures of the most abundant Paneth cell a-defensins in C57BL/6 mice differ from other mouse strains [90] . The genetic basis for C57BL/6 a-defensin proteome differences from other mouse strains was apparent by comparisons of the NIH C57BL/6 and Celera mixed-strain genomic assemblies, which are strikingly different. With regard to gene copy numbers, a repeated multigene cassette apparently unique to C57BL/6, and the orientation of several marker genes, the locus is highly divergent in the two genomic assemblies (Fig. 7) . Also, although mice lack neutrophil a-defensins, both assemblies contain approximately 20 a-defensin pseudogenes that are unproductive vestiges of functional rat myeloid a-defensin genes [90] .
Paneth cell secretory responses a-Defensin secretion by Paneth cells constitutes a key source of antimicrobial peptide activity released into the lumen of isolated mouse small intestinal crypts [1, 31] , and human Paneth cells also secrete a-defensin-rich granules when exposed to bacteria or their antigens [46, 157] .
Paneth cells secrete granules in a dose-dependent manner following interaction with bacterial antigens and in response to pharmacologic stimulation [31, [158] [159] [160] . Although the sensors remain unknown, carbamyl choline and bacterial antigenic stimuli both induce increased cytosolic [Ca 2? ] in Paneth cells by mobilization of intracellular and extracellular Ca 2? stores [158, 161] , which is inhibited by selective blockers of a Ca 2? -activated intermediate conductance K ? channel KCa3.1, or KCNN4. Compelling evidence now shows that Paneth cell a-defensins both mediate enteric innate immunity and determine the composition of the small intestinal microbiome [47, 162] .
a-Defensins and innate mucosal immunity
The contribution of Paneth cell a-defensins to enteric mucosal immunity is evident from the phenotype of mice that are transgenic for the human Paneth cell a-defensin, [78, 144] . In the lower half of the figure, Cys residues in the mature peptides (orange text) are underlined and highlighted in white text to denote the differences between the Crp1 a-defensin Cys distribution and that of the CRS1C and CRS4C peptide subfamilies HD5 [DEFA5-transgenic (?/?)] [47] . DEFA5-transgenic (?/?) mice express a human minigene consisting of 3 kb of genomic DNA encompassing the two peptide-coding exons of the DEFA5 HD5 gene, and expression occurs only in Paneth cells and at levels similar the endogenous mouse genes [47] . The fidelity of HD5 transgene expression in DEFA5-transgenic (?/?) mice suggests that cis-acting b-catenin/TCF-4 sites in the human Paneth cell HD5 gene are conserved and sufficient to direct gene transcription with accuracy. When challenged with Salmonella enterica serovar Typhimurium by oral inoculation, DEFA5-transgenic (?/?) mice were immune to infection, causing little perceptible disease in DEFA5-transgenic (?/?) mice [47] . Thus, addition of one new a-defensin to Paneth cell secretions of DEFA5-transgenic (?/?) mice was sufficient to confer immunity to orally-administered pathogenic bacteria. As the DEFA5-transgenic (?/?) mouse phenotype illustrates, differential sensitivities of bacterial species to specific a-defensins suggests that peptide diversity may confer selective advantage [47] .
a-Defensins secreted by Paneth cells shape the composition of the mouse small intestinal microbiome, apparently by selecting for peptide-tolerant resident microbial species in vivo [162] . For example, in the distal ileum of individual DEFA5-transgenic (?/?) mice, Firmicutes constituted 25.5% of bacterial species compared to 59% in FvB controls, the reference strain for the DEFA5 (?/?) transgenic animals. Also, Bacteroidetes made up 69.3% of bacterial species in DEFA5 (?/?) transgenic ileum, but in FvB controls, only 35% of species were in the Bacteroidetes group [162] . Thus, the ileal microflora of mice secreting a single added exogenous a-defensin was significantly different and genotype-dependent. Also, the distinct repertoire of C57BL/6 mouse Paneth cell a-defensins [90] appear to influence the ileal microbiome, because significant differences were found in the percent distribution of Firmicutes and Tenericutes species in C57BL/6 and FVB mice [162] .
Paneth cell defects and host defense
In health, Paneth cells are anatomically restricted to the small intestine. However, during episodes of inflammation throughout the gastrointestinal tract, as in Barrett's esophagus, gastritis, pancreatitis, Crohn's disease, and ulcerative colitis, Paneth cells may appear ectopically [17, 163, 164] . Fig. 7 Phylogenetic relationships between rat and mouse a-defensin, CRS1C, and CRS4C genes. The introns of mouse Paneth cell a-defensin, CRS1C and CRS4C genes from the NIH C57BL/6 and the mixed strain Celera assemblies, introns of rat enteric a-defensin genes, and second introns of rat myeloid a-defensin genes, and vestigial mouse myeloid a-defensin (DefmaN-ps) genes were used to construct the phylogenetic tree. The tree was rooted with the intron of the human a-defensin-5 (HD-5) gene, and construction of the tree involved the calculation of the proportion difference (p-distance) of aligned nucleotide sites of the entire intron sequences according to the neighbor-joining method. One thousand bootstrap replications were used to test the reliability of each branch. Solid lines maintain phylogenetic distances, but dashed lines do not in order to maintain legibility of sequences of the tree. Reprinted from [90] [22, 165] .
Intermediate cells with a-defensin-rich large dense core granules also appear dramatically in inflammation associated with nematode infection [166] , and also when Paneth cell numbers increase in mice treated with anti-CD3 to induce systemic T cell activation [167] . The molecular events that regulate expansion of the Paneth cell compartment under proinflammatory conditions are unknown. Defects in Paneth cell physiology and a-defensin biology may predispose individuals to infectious challenges. For example, MMP7-null mice are deficient in functional a-defensins due to defective intracellular proCrp processing, and their host defense to oral enteric infection is compromised in vivo [142] . Cystic fibrosis mice, null for the cystic fibrosis transmembrane conductance regulator, accumulate undissolved Paneth cell secretory granules in mucus-occluded crypts, resulting in bacterial overgrowth of small bowel, mucus colonization, and overgrowth by Enterobacteriaceae [168, 169] . In CD1d-null mice, bacterial exposure of germfree Cd1d-/-mice induces defective Paneth cell secretory granule ultrastructure which is accompanied by a deficit in degranulation, and bacterial colonization of the intestine is more rapid compared to wild-type mice under specific pathogen-free or germ-free conditions [170] .
Expression of Paneth cell secretory proteins is tightly regulated during Wnt-driven lineage determination, but certain Paneth cell gene products are also newly induced in response to microbial colonization or to changes in the microflora. Examples include the increased abundance of bactericidal ribonuclease angiogenin-4 and the C-type lectin RegIIIc in mice that are monocolonized with Bacteroides thetaiotaomicron relative to germ-free controls [171, 172] . Additionally, small intestinal expression of RegIIIc, RegIIIb, CRP-ductin, and RELMb is induced in mice lacking the toll-like receptor adapter MyD88 by oral bacterial infection with Listeria monocytogenes [173] . In this model, signaling to maintain intestinal homeostasis in response to infection is mediated by Paneth cell MyD88 activation, not by activation of myeloid cells [173, 174] . Also, oral infection of mice with Toxoplasma gondii induces Tlr9 mRNA accumulation, increased type I interferon (IFN) mRNA levels, and elevated Crp3 and Crp5 mRNA expression in C57BL/6 mice [175] . In Tlr9 -/-mice, responses to T. gondii were replicated by administration of IFN-b and were abrogated in IFNAR -/-mice [175] . The T. gondii effects are mediated by Tlr9-dependent production of type I IFNs, but whether the induction of Crps 3 and 5 is a direct or paracrine Paneth cell response to IFN-b is not unknown. Because C57BL/6 mice have several Crp3 and Crp5 gene copies [90] , distinguishing between enhanced transcription and posttranscriptional processing of already active genes or recruitment and activation of transcriptionally silent Crp genes during the infectious process is not feasible at this time.
The Paneth cell lineage is committed to the biosynthesis of secretory proteins as components of dense core granules (Figs. 1 and 2) . Genetic defects that target secretory pathways or induce autophagy or ER stress have adverse effects on ERrich Paneth cell homeostasis selectively and contribute to inflammatory bowel disease pathogenesis. In mice hypomorphic for the autophagy gene Atg16l1, Paneth cells accumulate apparent failed autophagy vesicles and are defective in secretion [19] . Because this remarkable Paneth cell phenotype is dependent both on the Atg16l1 genetic defect and on infection by a specific strain of mouse norovirus [176] , we have a definitive example showing that an individual with a predisposing IBD risk factor may be symptomfree until exposed to a specific infectious agent. Also, severe disruption of the unfolded protein response by selective deletion of Xbp1 in intestinal epithelial cells induces massive Paneth cell apoptosis and fulminant ileitis [20] . Thirdly, germline and inducible gene deletions of the protein disulfide isomerase, Anterior Gradient 2, results in goblet cell Mucin 2 deficiency [177] , expansion of the Paneth cell compartment, and severe terminal ileitis and colitis associated with induced ER stress [21] . Thus, mutations that adversely affect Paneth cell homeostasis and alter the composition of their secretions could compromise mucosal immunity by reducing a-defensin production levels, impairing Paneth cell secretion, or by adversely affecting granule solubility and the availability of functional a-defensins and secretory proteins in the crypt microenvironment [21, 177] . Also, Paneth cell dysbiosis may create a local deficiency of Paneth cell-derived signaling molecules that are required to sustain the Lgr5? crypt stem cell population and the integrity of the enteric barrier [22] . Judging from recent advances in the understanding of Paneth cell biology and complex mechanisms of enteric homeostasis, we can anticipate that these questions will be resolved in the near future.
